Genetic aspects of susceptibility, severity, and clinical expression in ankylosing spondylitis.

While twin studies have previously demonstrated high heritability of susceptibility to ankylosing spondylitis (AS), it is only recently that the involvement of genetic factors in determining the severity of the disease has been demonstrated. The genes involved in determining the rate of ankylosis in...

Full description

Bibliographic Details
Main Authors: Brown, M, Crane, A, Wordsworth, B
Format: Journal article
Language:English
Published: 2002
_version_ 1797083013451874304
author Brown, M
Crane, A
Wordsworth, B
author_facet Brown, M
Crane, A
Wordsworth, B
author_sort Brown, M
collection OXFORD
description While twin studies have previously demonstrated high heritability of susceptibility to ankylosing spondylitis (AS), it is only recently that the involvement of genetic factors in determining the severity of the disease has been demonstrated. The genes involved in determining the rate of ankylosis in AS are likely to be different from those involved in the underlying immunologic events, and represent important potential targets for treatment of AS. This article will describe the progress that has been made in the genetic epidemiology of AS, and in identifying the genes involved.
first_indexed 2024-03-07T01:36:06Z
format Journal article
id oxford-uuid:953b388e-0c22-4389-acca-b3fee463ba21
institution University of Oxford
language English
last_indexed 2024-03-07T01:36:06Z
publishDate 2002
record_format dspace
spelling oxford-uuid:953b388e-0c22-4389-acca-b3fee463ba212022-03-26T23:44:48ZGenetic aspects of susceptibility, severity, and clinical expression in ankylosing spondylitis.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:953b388e-0c22-4389-acca-b3fee463ba21EnglishSymplectic Elements at Oxford2002Brown, MCrane, AWordsworth, BWhile twin studies have previously demonstrated high heritability of susceptibility to ankylosing spondylitis (AS), it is only recently that the involvement of genetic factors in determining the severity of the disease has been demonstrated. The genes involved in determining the rate of ankylosis in AS are likely to be different from those involved in the underlying immunologic events, and represent important potential targets for treatment of AS. This article will describe the progress that has been made in the genetic epidemiology of AS, and in identifying the genes involved.
spellingShingle Brown, M
Crane, A
Wordsworth, B
Genetic aspects of susceptibility, severity, and clinical expression in ankylosing spondylitis.
title Genetic aspects of susceptibility, severity, and clinical expression in ankylosing spondylitis.
title_full Genetic aspects of susceptibility, severity, and clinical expression in ankylosing spondylitis.
title_fullStr Genetic aspects of susceptibility, severity, and clinical expression in ankylosing spondylitis.
title_full_unstemmed Genetic aspects of susceptibility, severity, and clinical expression in ankylosing spondylitis.
title_short Genetic aspects of susceptibility, severity, and clinical expression in ankylosing spondylitis.
title_sort genetic aspects of susceptibility severity and clinical expression in ankylosing spondylitis
work_keys_str_mv AT brownm geneticaspectsofsusceptibilityseverityandclinicalexpressioninankylosingspondylitis
AT cranea geneticaspectsofsusceptibilityseverityandclinicalexpressioninankylosingspondylitis
AT wordsworthb geneticaspectsofsusceptibilityseverityandclinicalexpressioninankylosingspondylitis